Earnings Call Transcripts·Nov 10, 2026, 11:00 AM ET

Fall AAFCO Regulatory Updates - BALCHEM CORP

BCPC

Financial Performance: The provided transcript is a regulatory update presentation by the Association of American Feed Control Officials (AFCO) hosted by Balchem; it contains no financial data, revenue figures, earnings, or profit margins related to a corporate earnings call.
Guidance and Future Outlook: AFCO is preparing for the 2027 edition of its Official Publication, which will include new ingredient definitions and regulatory updates; the association anticipates potential implementation extensions for the Pet Food Label Modernization policy (originally set for 2030) based on yearly reviews.
Business Segments and Product Lines: New ingredients approved for the 2027 publication include zinc L-selenomethionine complex, synthetic sodium alumina silicate, lytic bacteriophage, and black soldier fly larva oil; two ingredients (serine endopeptidase and grass-derived alkali lignin) have advanced through the SRIS process pending a January membership vote; new cat food nutrient profiles now enforce a 5g max phosphorus limit and a 1:1 calcium-to-phosphorus ratio.
Market and Competitive Landscape: The organization emphasizes global harmonization efforts through the International Cooperation for the Convergence of Technical Requirements (ICCF) and active participation in international feed regulator meetings, acknowledging the increasing global nature of the animal food industry.
Risks and Challenges: Key regulatory risks include the FDA's proposed mandatory GRAS notification rule (comment period closing December 9), which shifts the voluntary notification system to a compliance exercise with potential enforcement scrutiny; state-level challenges involve regulatory burnout, funding shortages, and the difficulty of policing e-commerce distribution channels.
Management Commentary and Tone: Management presents a collaborative, transparent tone focused on industry stability and harmonization, expressing support for the FDA's internal process improvements while advocating against the PER Act's preemption of state labeling authority and cautioning on the timeline for the FDA's final GRAS rule.
Analyst Questions and Answers: Q&A confirmed no current review for collagen as a primary ingredient, noted insufficient data for a dedicated "senior dog" nutrient profile, and clarified that AFCO's voluntary label review pilot and ingredient certification programs (aimed at marketing claims and safety compliance) are under consideration for 2027.
Other Key Points: FDA recently completed a pre-market ingredient review program evaluation, resulting in clearer disclosure requirements, earlier reviewer feedback, and a new internal policy manual (1244.3425) to reduce timeline uncertainty; the FDA CVM reorganization split the Office of Surveillance and Compliance into two specialized offices; the Senate version of the Farm Bill 2.0 includes language for the Innovative Feed Act, while the House version does not.

Company: BALCHEM CORP
Keywords: BALCHEM CORP